Champions Oncology, Inc. (CSBR) reported a significant decline in gross margin, dropping to 47% from 61% year-over-year due to increased costs in oncology revenues, totaling $8.8 million. The company attributed this decrease to over $2 million in outsourced radiolabeling work and a lack of prior-year licensing revenue. CSBR anticipates margin improvement as radiolabeling work transitions in-house.
In contrast, Capstone Energy+ Inc. (CEPL) saw its gross margin increase to 30.1% from 27.8%. The company introduced a design-for-manufacturing initiative that reduced production costs by 59%, lowering the cost per microturbine unit from $1,212 to $413. This cost-saving measure is expected to positively impact future gross margins. Zacks currently rates CEPL as Outperform.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
